This study is being carried out to see if ZD4054 is effective in treating prostate cancer and spread of cancer to the bone, and if so, how it compares with placebo (sugar pill). The study will also provide further information on the safety of ZD4054.

Official Title

Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Centre Study to Assess ZD4054 in Pain-Free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)


Study Type


Study Design

Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study

Further Details

Study Start

August 2004

Eligibility & Criteria

Ages Eligible for Study: 18 Years and aboveGenders Eligible for Study: Male CriteriaInclusion Criteria:- Surgically or medically castrated – Bone metastasis – Rising PSA Exclusion Criteria:- Opiate use – Prior chemotherapy

Total Enrolment


Contact Details

AustraliaResearch Site, Nedlands, Australia; Recruiting Australia, QueenslandResearch Site, Wolloongabba, Queensland, Australia; Not yet recruiting Australia, South AustraliaResearch Site, Ashford, South Australia, Australia; Recruiting Australia, VictoriaResearch Site, Wodonga, Victoria, Australia; Recruiting

All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.